These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 228868)

  • 21. T cell-mediated immunity to oncornavirus-induced tumors. III. Specific and nonspecific suppression in tumor-bearing mice.
    Plater C; Debré P; Leclerc JC
    Eur J Immunol; 1981 Jan; 11(1):39-44. PubMed ID: 6452278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of suppressor lymphocytes generated in vitro.
    Ferguson RM; Anderson SM; Simmons RL
    Transplantation; 1978 Nov; 26(5):331-9. PubMed ID: 309200
    [No Abstract]   [Full Text] [Related]  

  • 23. Original H-2d and alien H-2k-like antigens of a BALB/c fibrosarcoma as defined by in vitro and in vivo studies of cell-mediated immunity.
    Sensi M; Carbone G; Parmiani G
    Eur J Immunol; 1980 Sep; 10(9):671-8. PubMed ID: 6158452
    [No Abstract]   [Full Text] [Related]  

  • 24. Immunosuppressor T cells in tumor bearing host.
    Fujimoto S; Greene M; Sehon AH
    Immunol Commun; 1975; 4(3):201-17. PubMed ID: 1080741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Properties of reticulum cell sarcomas in SJL/J mice. VII. Nature of normal lymphoid cells proliferating in response to tumor cells.
    Lerman SP; Chapman-Alexander J; Umetsu D; Thorbecke GJ
    Cell Immunol; 1979 Mar; 43(1):209-13. PubMed ID: 380818
    [No Abstract]   [Full Text] [Related]  

  • 26. Defects in cell-mediated immunity during growth of a syngeneic simian virus-induced tumor.
    Howell SB; Dean JH; Law LW
    Int J Cancer; 1975 Jan; 15(1):152-69. PubMed ID: 236258
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Requirement of thymus-derived theta-positive lymphocytes for rejection of DNA virus (SV 40) tumors in mice.
    Tevethia SS; Blasecki JW; Waneck G; Goldstein AL
    J Immunol; 1974 Nov; 113(5):1417-23. PubMed ID: 4371155
    [No Abstract]   [Full Text] [Related]  

  • 28. H-2 antigen requirements in the in vitro induction of SV40-specific cytotoxic T lymphocytes.
    Gooding LR; Edwards CB
    J Immunol; 1980 Mar; 124(3):1258-62. PubMed ID: 6244348
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxic effect of lymphocytes from pregnant mice on cultivated tumor cells. I. Specificity, nature of effector cells and blocking by serum.
    Hellström I; Hellström KE
    Int J Cancer; 1975 Jan; 15(1):1-16. PubMed ID: 1168624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor inhibiting capacity of spleen and lymph node cells from mice with murine sarcoma virus (MSV-M)-induced tumors.
    Weiland E; Mussgay M
    Z Immunitatsforsch Exp Klin Immunol; 1975 Nov; 150(5):414-23. PubMed ID: 181922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delayed hypersensitivity to simian virus 40 tumor cells in BALB-c mice demonstrated by a radioisotopic foot-pad assay.
    Paranjpe MS; Boone CW
    J Natl Cancer Inst; 1972 Feb; 48(2):563-6. PubMed ID: 4347042
    [No Abstract]   [Full Text] [Related]  

  • 32. Antibody blockade of lysis by T lymphocyte effectors generated against syngeneic SV40 transformed cells.
    Gooding LR
    J Immunol; 1979 Jun; 122(6):2328-36. PubMed ID: 221583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antigen recognition by T lymphocytes. 3. Evidence for two populations of thymus-dependent rosette-forming cells in spleen and lymph nodes.
    Bach JF; Dardenne M
    Cell Immunol; 1973 Mar; 6(3):394-406. PubMed ID: 4540244
    [No Abstract]   [Full Text] [Related]  

  • 34. Characterization of cytostatic effector lymphocytes during the development of a syngeneic lymphosarcoma in C3H mice: use of monoclonal reagents to identify T-cell subsets.
    Matossian-Rogers A; Taidi B
    Cell Immunol; 1983 Dec; 82(2):292-307. PubMed ID: 6606491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cellular immune reactions during the growth of malignant tumors (author's transl)].
    Grundmann E
    Arch Geschwulstforsch; 1974; 43(2):115-23. PubMed ID: 4546592
    [No Abstract]   [Full Text] [Related]  

  • 36. Lymphocytes in mice with membrane antigens common to human thymocytes.
    Kawaoi A; Naito K; Uchida M; Kamiya K; Shikata T
    Adv Exp Med Biol; 1982; 149():275-80. PubMed ID: 6983216
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunogenic properties of a soluble tumor rejection antigen (TSTA) from a Simian virus 40-induced sarcoma.
    Rogers MJ; Law LW
    Int J Cancer; 1979 Jan; 23(1):89-96. PubMed ID: 83307
    [No Abstract]   [Full Text] [Related]  

  • 38. High frequency of T lineage lymphocytes in nude mouse spleen.
    Loor F; Roelants GE
    Nature; 1974 Sep; 251(5472):229-30. PubMed ID: 4138060
    [No Abstract]   [Full Text] [Related]  

  • 39. Cell-mediated immune reaction against tumors induced by oncornaviruses. II. Nature of the effector cells in tumor-cell cytolysis.
    Leclerc JC; Gomard E; Plata F; Levy JP
    Int J Cancer; 1973 Mar; 11(2):426-32. PubMed ID: 4545387
    [No Abstract]   [Full Text] [Related]  

  • 40. Regulation of cell-mediated cytotoxicity. II. Synergism of two types of thymus dependent cells in vivo.
    Sabbadini E
    Cell Immunol; 1975 Jul; 18(1):76-87. PubMed ID: 237633
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.